Thermo Fisher Scientific (NYSE:TMO) recently launched its 5L DynaDrive Single-Use Bioreactor, enhancing their offerings in bioprocessing. This announcement, coupled with their collaboration with NSG ...

Thermo Fisher Scientific shows strong fundamentals, consistent earnings growth, and solid financial health, making it a ...

Thermo Fisher Scientific Inc. has introduced the 5L DynaDrive Single-Use Bioreactor, expanding the company's portfolio of ...

Following the successful Series 2 PRO PLUS launch, Celluma Light Therapy by BioPhotas, Inc., announces the next light therapy solution for 2025 - the full-body Series 2 DELUX.  Sitting at the top of ...

This webinar will provide an overview of clustered regularly interspaced short palindromic repeats (CRISPR) prime editing, a groundbreaking genome-editing technology that offers unprecedented accuracy ...

Growth Drivers include demand for protein-based drugs, rise in chronic disease prevalence, precision medicine expansion, biotech advancements, and AI-driven design tools.Dublin, April 14, 2025 (GLOBE ...

Discover how a structural breakthrough in the chikungunya virus is opening new avenues for antiviral drug development and ...